Skip to content
(614)355-5560
Central Region
December 1, 2022
Amphetamine Mixed Salts (Adderall® and generic formulations) Shortage

Alternative Formulary Recommendations

This guide serves as a resource to aid in decision-making for stimulant dose conversions. This guide should not be considered a substitute for clinical judgement, and all patients should be monitored closely for clinical and adverse effects, especially when starting a new medication.

The table below is not an exhaustive list of all available options, but contains the options most similar to Adderall XR® as a dosage form. The Partners For Kids ADHD prescribing resource includes a larger table with more options and can be found here.

General Recommendations:

  • Utilize this guide by comparing current dosages of amphetamine mixed salts to the equivalent methylphenidate dose.
  • No specific guidance is available in literature for switching from amphetamine mixed salts to methylphenidate at direct doses. Consider switching at half of the methylphenidate dose shown, particularly if adverse events are a concern. Dosage increases can occur every 7 days if the new medication is well tolerated and increase is needed to improve symptom control.
  • When switching to a new medication, regular follow up is recommended to ensure there are no significant adverse effects.
  • Patient response to different stimulant classes can vary. Be prepared to increase or decrease a dose based upon efficacy and safety in each patient who required a switch.
  • The Partners For Kids prescribing resource linked above provides guidance on dosage adjustments.

 

All listed options are covered on Ohio Department of Medicaid’s Unified Preferred Drug List.

Related Articles
Pharmacy Updates
November 30, 2023
Flovent® Brand Name Inhalers Are Being Discontinued
Read More
Pharmacy Updates
November 30, 2023
PFK Asthma Risk Portal: Identify and Learn About Your High-Risk Asthma Patients
Learn more about the Asthma Risk Portal and view the training manual.
Read More
Pharmacy Updates
November 17, 2023
Update: Nirsevimab 100 mg Syringe Shortage
Learn more about the Nirsevimab 100 mg Syringe Shortage.
Read More
Pharmacy Updates
October 20, 2023
Quarterly Update for Partners For Kids Pediatric-Focused Unified Preferred Drug List
Access the most recent unified preferred drug list.
Read More
Pharmacy Updates
October 20, 2023
Partners For Kids Coverage Tools Support Cost Savings and Decrease Prior Authorization Burden
Read how Partners For Kids pharmacy resources can help providers align therapy decisions with managed care organization’s formularies, generate cost savings and avoid prior authorizations.
Read More
Pharmacy Updates
October 12, 2023
Respiratory Syncytial Virus (RSV) Prevention Resource
Read More